ML-2T – 30MG
$17.33
ML-2T (30 mg) — dual GLP/GIP receptor agonist analogue studied for its coordinated effects on glucose regulation, lipid metabolism, and energy balance. Research use only.
Test Results
Research-use onlyValues shown are provided for identity/quality verification only. No medical, clinical, or functional claims are made or implied.
In stock
ML-2T — Research Peptide
Description
ML-2T is a proprietary code-designated peptide analogue within the incretin receptor research class.
It has been studied for its dual agonist activity at the GLP and GIP receptor sites, supporting investigations into coordinated signaling that influences glucose regulation, lipid metabolism, and energy expenditure.
In experimental models, this dual-pathway activity has been associated with enhanced metabolic efficiency, improved nutrient utilization, and adaptive modulation of glycemic control.
ML-2T is of growing interest in in-vitro research focused on integrated metabolic signaling and nutrient response mechanisms.
This material is supplied in lyophilized powder form and intended strictly for in-vitro and laboratory research by qualified professionals.
Specifications
- Form: Lyophilized peptide (powder)
- Purity: ≥ 99% (HPLC verified)
- Storage: −20 °C or below; avoid repeated freeze–thaw cycles
- Solvent: Reconstitute with sterile bacteriostatic water (for research use only)
- Molecular Class: Dual GLP/GIP receptor agonist analogue
- CAS Reference: Available upon request
Available Variants
- 30 mg vial
Disclaimer
For research use only. Not for human or animal consumption, therapeutic use, or diagnostic procedures.
By purchasing, the customer confirms they are a qualified researcher and understands the intended use.
Related products
